hydroxyitraconazole has been researched along with Candidiasis, Oral in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beijnen, JH; Chuenyam, T; Huitema, AD; Koks, CH; Kroon, ED; Lange, JM; Sparidans, RW | 1 |
Ajana, F; Bazin, C; Chwetzoff, E; Datry, A; Le Moing, JP; Levron, JC; Reynes, J | 1 |
Cartledge, JD; Gazzard, BG; Midgely, J | 1 |
2 trial(s) available for hydroxyitraconazole and Candidiasis, Oral
Article | Year |
---|---|
Population pharmacokinetics of itraconazole in Thai HIV-1-infected persons.
Topics: Adult; Antifungal Agents; Bayes Theorem; Biological Availability; Candidiasis, Oral; Cohort Studies; Dose-Response Relationship, Drug; HIV Infections; Humans; Itraconazole; Models, Biological; Thailand; Time Factors | 2003 |
Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Area Under Curve; Biological Availability; Candidiasis, Oral; Chromatography, High Pressure Liquid; Female; Humans; Itraconazole; Male; Middle Aged; Saliva | 1997 |
1 other study(ies) available for hydroxyitraconazole and Candidiasis, Oral
Article | Year |
---|---|
Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Capsules; Chemistry, Pharmaceutical; Cohort Studies; Humans; Itraconazole; Male; Solutions | 1997 |